Kelly's project will be a probe of new treatments such as weight-loss drugs and cell and gene therapies offering hope to Medicaid patients with a range of diseases. But the treatments’ immense cost creates significant gaps in access to potentially life-saving care based on class, race and geography.
Kelly Hooper
2025 AHCJ Reporting Fellow on Health Care Performance, Politico
